Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222163 · ClinicalTrials.gov registry record · NA
Stuttering and Neuromodulation
A NA study of Stuttering, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT07222163: Recruiting NA study of Stuttering, sponsored by NYU Langone Health.
NCT07222163 is a NA study of Stuttering that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 16 participants, below the 773-participant average among 6 other Stuttering trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07222163, a NA study of Stuttering, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect preliminary data on the efficacy of transcranial direct current stimulation (tDCS) combined with traditional behavioral techniques to reduce stuttering severity and negative impact in adults who stutter. The study also aims to explore neuroplastic changes (i.e., regional activation and functional connectivity) resulting from combined tDCS + speech therapy.
Primary Outcome
The Stuttering Severity Instrument-4th Edition (SSI-4) provides a total score that is compared to age-specific norms to determine severity, with ranges for "Very Mild" to "Very Severe". The SSI-4 calculates individual scores for frequency (2-18), duration (2-18), and physical concomitants (0-20). These individual scores are combined to create a total score, which is then ranked against norms to provide a verbal severity descriptor, such as mild, moderate, severe, or very severe.
Conditions Studied
Interventions
- DEVICE Soterix Medical 1x1 tDCS system
- BEHAVIORAL Speech therapy sessions
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-09-04 |
| Est. Completion | 2027-10 |
| Phase | NA |
What NCT07222163 shows while recruiting
NCT07222163 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 773-participant average among 6 other Stuttering trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Stuttering appearing as the primary indexed condition, and to 2 interventions - of which Soterix Medical 1x1 tDCS system is the first listed.
NCT07222163 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07222163 about?
NCT07222163 is a clinical study titled "Stuttering and Neuromodulation". The purpose of this study is to collect preliminary data on the efficacy of transcranial direct current stimulation (tDCS) combined with traditional behavioral techniques to reduce stuttering severity and negative impact in adults who stutter. The study also aims to explore neuroplastic changes (i.e...
What is the current status of trial NCT07222163?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-09-04. Estimated completion is 2027-10.
What conditions does trial NCT07222163 study?
This clinical trial studies the following conditions: Stuttering.
What interventions are being tested in trial NCT07222163?
The interventions under investigation include: Soterix Medical 1x1 tDCS system (DEVICE), Speech therapy sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT07222163?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222163 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stuttering
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exploring the Nature, Assessment and Treatment of Stuttering
RECRUITING · NA
-
Network Connectivity and Temporal Processing in Adolescents Who Stutter
RECRUITING · NA
-
Speech Processing in Stuttering
COMPLETED · NA
-
The Development of Stuttering in Young Children
RECRUITING
-
Characteristics of Idiopathic Familial Speech Disorders
COMPLETED
-
Genetic Factors Related to Stuttering
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI